Clinical efficacy of the drug 200 mg silver proteinate in the complex therapy of acute infectious rhinitis in children, which occurred as part of an acute respiratory infection
| Autor: | A. B. Kiselev, V. A. Chaukina, N. E. Terskova, Kh. T. Abdulkerimov |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Drug
medicine.medical_specialty business.industry media_common.quotation_subject Respiratory infection Geology Ocean Engineering Silver proteinate chemistry.chemical_compound Infectious Rhinitis chemistry Internal medicine medicine Clinical efficacy business Water Science and Technology media_common |
| Zdroj: | Russian Otorhinolaryngology. 20:88-95 |
| ISSN: | 1810-4800 |
| DOI: | 10.18692/1810-4800-2021-4-88-95 |
| Popis: | The effectiveness of pharmacotherapy of acute infectious rhinitis in children by means of drugs from the list of medicines of the J00 Standard and in addition to this pharmacotherapy with the drug silver proteinate – 200 mg nasal spray Sialor® (manufacturer of JSC «Production Pharmaceutical Company “Obnovlenie”, Russia) was evaluated in a multicenter randomized comparative study. A higher quality of treatment was demonstrated when using 200 mg silver proteinate (Sialor®) in the form of a nasal spray in complex therapy. The article presents evidence of the feasibility of including the drug 200 mg silver proteinate in the list of medicines of the J00 Standard. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|